Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
2022-01-01 Vellano, Cp; White, Mg; Andrews, Mc; Chelvanambi, M; Witt, Rg; Daniele, Jr; Titus, M; Mcquade, Jl; Conforti, F; Burton, Em; Lastrapes, Mj; Ologun, G; Cogdill, Ap; Morad, G; Prieto, P; Lazar, Aj; Chu, Ys; Han, Gc; Khan, Maw; Helmink, B; Davies, Ma; Amaria, Rn; Kovacs, Jj; Woodman, Se; Patel, S; Hwu, P; Peoples, M; Lee, Je; Cooper, Za; Zhu, Hf; Gao, G; Banerjee, H; Lau, M; Gershenwald, Je; Lucci, A; Keung, Ez; Ross, Mi; Pala, L; Pagan, E; Segura, Rl; Liu, Q; Borthwick, Ms; Lau, E; Yates, Ms; Westin, Sn; Wani, K; Tetzlaff, Mt; Haydu, Le; Mahendra, M; Ma, Xy; Logothetis, C; Kulstad, Z; Johnson, S; Hudgens, Cw; Feng, Np; Federico, L; Long, Gv; Futreal, Pa; Arur, S; Tawbi, Ha; Moran, Ae; Wang, Lh; Heffernan, Tp; Marszalek, Jr; Wargo, Ja
Boosting anticancer immunotherapy through androgen receptor blockade
2022-01-01 Pala, L; De Pas, T; Conforti, F
Molecular features and clinical outcome of lung malignancies in very young people
2015-01-01 Catania, C; Botteri, E; Barberis, M; Conforti, F; Toffalorio, F; De Marinis, F; Boselli, S; Noberasco, C; Delmonte, A; Spitaleri, G; Spaggiari, L; Rotmensz, N; Passaro, A; Bazolli, B; Alfieri, M; Manzotti, M; Fumagalli, C; Milani, A; De Pas, T
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials
2022-01-01 Conforti, F; Pala, L; De Pas, T; He, Yf; Giaccone, G
Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome
2019-01-01 Pala, L; Nezi, L; De Pas, T; Pennacchioli, E; Cocorocchio, E; Ferrucci, P; Conforti, F; Goldhirsch, A
PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors
2016-01-01 Alberobello, At; Wang, Ys; Beerkens, Fj; Conforti, F; Mccutcheon, Jn; Rao, Gh; Raffeld, M; Liu, J; Rahhal, R; Zhang, Yw; Giaccone, G
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study
2022-01-01 Conforti, F; Gronchi, A; Penel, N; Jones, Rl; Broto, Jm; Sala, I; Bagnardi, V; Napolitano, A; Pala, L; Pennacchioli, E; Catania, C; Queirolo, P; Grigani, G; Merlini, A; Stacchiotti, S; Comandone, A; Vincenzi, B; Quagliuolo, V; Bertuzzi, A; Boglione, A; Palassini, E; Baldi, Gg; Blay, Jy; Ryckewaert, T; Toulmonde, M; Italiano, A; Le Cesne, A; Ray-Coquard, I; Cruz, J; Hernandez-Leon, Cn; Trufero, Jm; Moura, Dd; Muniz, Nh; De Pas, T
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
2022-01-01 Corso, Giovanni; D'Ecclesiis, Oriana; Magnoni, Francesca; Mazzotta, Erica; Conforti, Fabio; Veronesi, Paolo; Sajjadi, Elham; Venetis, Konstantinos; Fusco, Nicola; Gandini, Sara
Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer Critical Analysis of Strengths, Weaknesses, and Misinterpretations
2022-01-01 Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Colleoni, M; Buyse, M; Hortobagyi, G; Gianni, L; Winer, E; Loibl, S; Cortes, J; Piccart, M; Wolff, Ac; Viale, G; Gelber, Rd
EPIDERMAL GROWTH FACTORS TYROSINE-KINASE INHIBITORS (EGFR-TKI) EFFICACY IN NSCLC PATIENTS WITH HIGH POLYSOMY OF CHROMOSOME 7 AND EGFR/KRAS WILD TYPE TUMORS
2014-01-01 Toffalorio, F; Conforti, F; Spitaleri, G; Catania, C; Noberasco, C; Lazzari, C; Barberis, M; De Marinis, F; De Pas, T
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers
2023-01-01 Zagami, P.; Comandone, A.; Fiore, M.; Giulio Baldi, G.; Grignani, G.; Vincenzi, B.; Gronchi, A.; Antonarelli, G.; Boglione, A.; Pennacchioli, E.; Curigliano, G.; Conforti, F.; De Pas, T. M.
Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors
2017-01-01 Conforti, F; Zhang, X; Rao, Gh; De Pas, T; Yonemori, Y; Rodriguez, Ja; Mccutcheon, Jn; Rahhal, R; Alberobello, At; Wang, Ys; Zhang, Yw; Guha, U; Giaccone, G
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
2019-01-01 Conforti, F.; Pala, L.; Bagnardi, V.; Viale, G.; De Pas, T.; Pagan, E.; Pennacchioli, E.; Cocorocchio, E.; Ferrucci, P. F.; De Marinis, F.; Gelber, R. D.; Goldhirsch, A.
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy
2022-01-01 Corti, C; Conforti, F; Pala, L; Catania, C; Cocorocchio, E; Ferrucci, Pf; Curigliano, G; Queirolo, P; De Pas, T
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action
2022-01-01 Pala, L; De Pas, T; Conforti, F
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
2024-01-01 Valenza, Carmine; De Pas, Tommaso Martino; Gaeta, Aurora; Castellano, Grazia; Santoro, Celeste; Corona, Amedeo; Chiappini, Giulia; Vivanet, Grazia; Trapani, Dario; Coppola, Sara; Conforti, Fabio; Mattar, Denise; Gandini, Sara; Veronesi, Paolo; Pennacchioli, Elisabetta; Curigliano, Giuseppe
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
2018-01-01 Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Martinetti, M; Viale, G; Gelber, Rd; Goldhirsch, A
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
2020-01-01 Cocorocchio, E; Martinoli, C; Gandini, S; Pala, L; Conforti, F; Stucchi, S; Mazzarol, G; Ferrucci, P
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study
2023-01-01 Conforti, F; Pala, L; Vivanet, G; Corti, C; Catania, C; Maiettini, D; Varano, G; Di Venosa, B; Curigliano, G; Salvini, P; Berardi, R; Ballatore, Z; De Pas, Tm
Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling
2015-01-01 Conforti, F; Wang, Ys; Rodriguez, Ja; Alberobello, At; Zhang, Yw; Giaccone, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy | 1-gen-2022 | Vellano, Cp; White, Mg; Andrews, Mc; Chelvanambi, M; Witt, Rg; Daniele, Jr; Titus, M; Mcquade, Jl; Conforti, F; Burton, Em; Lastrapes, Mj; Ologun, G; Cogdill, Ap; Morad, G; Prieto, P; Lazar, Aj; Chu, Ys; Han, Gc; Khan, Maw; Helmink, B; Davies, Ma; Amaria, Rn; Kovacs, Jj; Woodman, Se; Patel, S; Hwu, P; Peoples, M; Lee, Je; Cooper, Za; Zhu, Hf; Gao, G; Banerjee, H; Lau, M; Gershenwald, Je; Lucci, A; Keung, Ez; Ross, Mi; Pala, L; Pagan, E; Segura, Rl; Liu, Q; Borthwick, Ms; Lau, E; Yates, Ms; Westin, Sn; Wani, K; Tetzlaff, Mt; Haydu, Le; Mahendra, M; Ma, Xy; Logothetis, C; Kulstad, Z; Johnson, S; Hudgens, Cw; Feng, Np; Federico, L; Long, Gv; Futreal, Pa; Arur, S; Tawbi, Ha; Moran, Ae; Wang, Lh; Heffernan, Tp; Marszalek, Jr; Wargo, Ja | |
| Boosting anticancer immunotherapy through androgen receptor blockade | 1-gen-2022 | Pala, L; De Pas, T; Conforti, F | |
| Molecular features and clinical outcome of lung malignancies in very young people | 1-gen-2015 | Catania, C; Botteri, E; Barberis, M; Conforti, F; Toffalorio, F; De Marinis, F; Boselli, S; Noberasco, C; Delmonte, A; Spitaleri, G; Spaggiari, L; Rotmensz, N; Passaro, A; Bazolli, B; Alfieri, M; Manzotti, M; Fumagalli, C; Milani, A; De Pas, T | |
| Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials | 1-gen-2022 | Conforti, F; Pala, L; De Pas, T; He, Yf; Giaccone, G | |
| Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome | 1-gen-2019 | Pala, L; Nezi, L; De Pas, T; Pennacchioli, E; Cocorocchio, E; Ferrucci, P; Conforti, F; Goldhirsch, A | |
| PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors | 1-gen-2016 | Alberobello, At; Wang, Ys; Beerkens, Fj; Conforti, F; Mccutcheon, Jn; Rao, Gh; Raffeld, M; Liu, J; Rahhal, R; Zhang, Yw; Giaccone, G | |
| Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study | 1-gen-2022 | Conforti, F; Gronchi, A; Penel, N; Jones, Rl; Broto, Jm; Sala, I; Bagnardi, V; Napolitano, A; Pala, L; Pennacchioli, E; Catania, C; Queirolo, P; Grigani, G; Merlini, A; Stacchiotti, S; Comandone, A; Vincenzi, B; Quagliuolo, V; Bertuzzi, A; Boglione, A; Palassini, E; Baldi, Gg; Blay, Jy; Ryckewaert, T; Toulmonde, M; Italiano, A; Le Cesne, A; Ray-Coquard, I; Cruz, J; Hernandez-Leon, Cn; Trufero, Jm; Moura, Dd; Muniz, Nh; De Pas, T | |
| Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis | 1-gen-2022 | Corso, Giovanni; D'Ecclesiis, Oriana; Magnoni, Francesca; Mazzotta, Erica; Conforti, Fabio; Veronesi, Paolo; Sajjadi, Elham; Venetis, Konstantinos; Fusco, Nicola; Gandini, Sara | |
| Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer Critical Analysis of Strengths, Weaknesses, and Misinterpretations | 1-gen-2022 | Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Colleoni, M; Buyse, M; Hortobagyi, G; Gianni, L; Winer, E; Loibl, S; Cortes, J; Piccart, M; Wolff, Ac; Viale, G; Gelber, Rd | |
| EPIDERMAL GROWTH FACTORS TYROSINE-KINASE INHIBITORS (EGFR-TKI) EFFICACY IN NSCLC PATIENTS WITH HIGH POLYSOMY OF CHROMOSOME 7 AND EGFR/KRAS WILD TYPE TUMORS | 1-gen-2014 | Toffalorio, F; Conforti, F; Spitaleri, G; Catania, C; Noberasco, C; Lazzari, C; Barberis, M; De Marinis, F; De Pas, T | |
| The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers | 1-gen-2023 | Zagami, P.; Comandone, A.; Fiore, M.; Giulio Baldi, G.; Grignani, G.; Vincenzi, B.; Gronchi, A.; Antonarelli, G.; Boglione, A.; Pennacchioli, E.; Curigliano, G.; Conforti, F.; De Pas, T. M. | |
| Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors | 1-gen-2017 | Conforti, F; Zhang, X; Rao, Gh; De Pas, T; Yonemori, Y; Rodriguez, Ja; Mccutcheon, Jn; Rahhal, R; Alberobello, At; Wang, Ys; Zhang, Yw; Guha, U; Giaccone, G | |
| Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis | 1-gen-2019 | Conforti, F.; Pala, L.; Bagnardi, V.; Viale, G.; De Pas, T.; Pagan, E.; Pennacchioli, E.; Cocorocchio, E.; Ferrucci, P. F.; De Marinis, F.; Gelber, R. D.; Goldhirsch, A. | |
| Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy | 1-gen-2022 | Corti, C; Conforti, F; Pala, L; Catania, C; Cocorocchio, E; Ferrucci, Pf; Curigliano, G; Queirolo, P; De Pas, T | |
| Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action | 1-gen-2022 | Pala, L; De Pas, T; Conforti, F | |
| Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center | 1-gen-2024 | Valenza, Carmine; De Pas, Tommaso Martino; Gaeta, Aurora; Castellano, Grazia; Santoro, Celeste; Corona, Amedeo; Chiappini, Giulia; Vivanet, Grazia; Trapani, Dario; Coppola, Sara; Conforti, Fabio; Mattar, Denise; Gandini, Sara; Veronesi, Paolo; Pennacchioli, Elisabetta; Curigliano, Giuseppe | |
| Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis | 1-gen-2018 | Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Martinetti, M; Viale, G; Gelber, Rd; Goldhirsch, A | |
| Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors | 1-gen-2020 | Cocorocchio, E; Martinoli, C; Gandini, S; Pala, L; Conforti, F; Stucchi, S; Mazzarol, G; Ferrucci, P | |
| High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study | 1-gen-2023 | Conforti, F; Pala, L; Vivanet, G; Corti, C; Catania, C; Maiettini, D; Varano, G; Di Venosa, B; Curigliano, G; Salvini, P; Berardi, R; Ballatore, Z; De Pas, Tm | |
| Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling | 1-gen-2015 | Conforti, F; Wang, Ys; Rodriguez, Ja; Alberobello, At; Zhang, Yw; Giaccone, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26266
Data di pubblicazione
- In corso di stampa10
- 2020 - 20268444
- 2010 - 201911540
- 2000 - 20094513
- 1990 - 19991428
- 1980 - 1989308
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE358
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...259
- ANNALS OF ONCOLOGY239
- CANCERS223
- THE JOURNAL OF NUCLEAR MEDICINE221
- PLOS ONE211
- EUROPEAN JOURNAL OF CANCER197
- GASTROINTESTINAL ENDOSCOPY193
- ALLERGY178
- JOURNAL OF CLINICAL ONCOLOGY169
Keyword
- Humans2102
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19408
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng18439
- ita405
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
- und1
Accesso al fulltext
- no fulltext24066
- reserved1312
- open888